Indonesia court restores patent evergreening barrier, aiding generics
By Roffie Kurniawan ( September 8, 2026, 07:29 GMT | Insight) -- Indonesia’s pharmaceutical patent landscape has shifted back in favor of generic drugmakers after the Constitutional Court restored restrictions designed to prevent patent “evergreening.”Indonesia’s pharmaceutical patent landscape has shifted back in favor of generic drugmakers after the Constitutional Court restored restrictions designed to prevent patent “evergreening,” making it harder for originator companies to extend exclusivity through new uses or minor modifications of existing medicines....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.